Hyperphosphatemia in chronic kidney disease
PDF (Español)
HTML (Español)

How to Cite

Musso C. Hyperphosphatemia in chronic kidney disease. Rev. Colomb. Nefrol. [Internet]. 2017 Feb. 7 [cited 2024 Jul. 25];4(1):15-6. Available from: https://revistanefrologia.org/index.php/rcn/article/view/284
PDF (Español)
HTML (Español)


1. Hsu C. Calcium and phosphate metabolism in chronic renal disease. Berlin: Springer. 2006.

2. Musso CG, Guelman R, Varela F, Pidoux R, Schreck C, Rosa G, Plantalech L, Algranati L. Ibandronate improves hyperphosphatemia in dialysis patients with hyperparathyroidism. Int Urol Nephrol. 2004;36(4):625-7. Disponible en: https://doi.org/10.1007/s11255-004-2077-5

3. Musso CG, Juarez R, Vilas M, Navarro M, Rivera H, Jauregui R. Renal calcium, phosphorus, magnesium and uric acid handling: comparison between stage III chronic kidney disease patients and healthy oldest old. Int Urol Nephrol. 2012;44(5):1559-62. Disponible en: https://doi.org/10.1007/s11255-012-0230-0

4. Musso CG, Rodriguez Macias E, Medina A, Heredia A, Juarez R, Rivera H, de Miguel R. Valores comparados de excreción fraccional de magnesio y fósforo peritoneal y urinario entre pacientes en diálisis peritoneal con diuresis residual, insuficiencia renal crónica (estadio III) y voluntarios sanos. Electron J Biomed 2012;3:22-26. Disponible en: http://biomed.uninet.edu/2012/n3/musso-es.html

5. Gonzalez-Sanchidrian S, Deira J. Progressive hemodialysis: Is it the future, or the present? Seminars in dialysis. 2017; 30(1): 80. Disponible en: https://doi.org/10.1111/sdi.12564

6. Plante GE, Lafreniere MC, Tam PT, Sirois P. Effect of indapamide on phosphate metabolism and vascular reactivity.Am J Med. 1988;84(1B):26-30. Disponible en: https://doi.org/10.1016/S0002-
No national or foreign publication may partially or totally reproduce or translate Revista Colombiana de Nefrología articles or abstracts without prior written permission from the journal’s Editorial Board.




Download data is not yet available.